Post-treatment plasma omentin levels in patients with stage III colon carcinoma

Journal of B.U.ON.

Volumn 19, Issue 3, 2014, Pages 681-685

  Uyeturk, Ummugul ^a   Alcelik, Aytekin ^a   Aktas, Gulali ^a   Tekce, Buket Kin ^a  

^a Abant Izzet Baysal   (Turkey)

Author keywords

Adipocytokine; Colon carcinoma obesity; Omentin; Stage III

Indexed keywords

ADIPOCYTOKINE; CREATININE; FLUOROURACIL; FOLINIC ACID; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OMENTIN; OXALIPLATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADIPOSE TISSUE; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; COLON CARCINOMA; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL CARCINOMA; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIPLE CYCLE TREATMENT; OMENTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; BLOOD; COLONIC NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; COLONIC NEOPLASMS; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 84908453991     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62: 10-29.
2. Kim E, Coelho D, Blachier F. Review of the association between meat consumption and risk of colorectal cancer. Nutr Res 2013;33: 983-994.
3. Donohoe CL Pidgeon GP, Lysaght J, Reynolds JV. Obesity and gastrointestinal cancer. Br J Surg 2010: 97: 628-642
4. Kant P, Hull MA Excess body weight and obesity~the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol 2011;8: 224-238.
5. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes 2013;1-11. http://dx.doi.org/10.1155/2013/291546.
6. Aleksandrova K, Nimptsch K, Pischon T. Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk. Curr Nutr Rep 2013;2: 1-9.
7. Beltowski J. Adiponectin and resistin-new hormones of white adipose tissue. Med Sci Monit 2003;9: RA55-61.
8. Ukkola O, Santaniemi M. Adiponectin: A link between excess adiposity and associated comorbidities? J Mol Med (Beri) 2002;80: 696-702.
9. Housa D, Housova J, Vernerova Z, Haluzik M. Adipo-cytokines and cancer. Physiol Res 2006;55: 233-244.
10. Schaffler A, Neumeier M, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005;1732: 96-102.
11. Yang RZ, Lee MJ, Hu H et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: Possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006;290: E1253-1261.
12. de Souza Batista CM, Yang RZ, Lee M J et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56: 1655-1661.
13. Andre T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009;27: 3109-3116.
14. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: A review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 200226: 1407-1433.
15. Arpaci F, Yilmaz MI, Ozet A et al. Low serum leptin level in colon cancer patients without significant weight loss. Tumori 2002;88: 147-149.
16. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CQ patients. Int J Colorectal Dis 2009;24: 275-281.
17. Otake S, Takeda H, Fujishima S et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol 2010;16: 1252-1257.
18. Wei EK, Giovannucci E, Fuchs CS, Wille WC, Man-tzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study. J Natl Cancer Inst 2005;97: 1688-1694.
19. Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 2009;10: 610-616.
20. Nakajima TE, Yamada Y, Hamano T et al. Adipocy-tokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010;101: 1286-1291.
21. Martinez-Garcia MA, Montes-Nieto R, Fernandez-Duran E et aL Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2013;98: E388-396.
22. Moreno-Navarrete JM, Catalan V, Ortega F et al. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 2010;7: 1-6.
23. Fazeli MS, Dashti H, Akbarzadeh S et al. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine 2013;62: 81-85.
24. Zheng L, Weng M, Qi M et al Aberrant expression of in-telectin-1 in gastric cancer its relationship with clinico- pathological features and prognosis. J Cancer Res Clin Oncol 2012;138: 163-172.
25. Zhang YY, Zhou LM. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirtl-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur J Pharmacol 2013;698: 137-144.